Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
He added that the US market relies heavily on generic drugs rather than branded products, which Novo Nordisk does not sell. Competitor Eli Lilly (LLY) recently announced a $27 billion investment in ...
South Africa's competition watchdog probes Novo Nordisk and Sanofi for potential anti-competitive practices in the insulin pen market South Africa’s competition watchdog is investigating ...
This collaboration unites Novo Nordisk’s deep therapeutic knowledge and drug development experience with Gensaic’s novel protein design technology with the aim to discover tissue targeting ...
We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on ValueInvestorsClub by cable888. In this article, we will summarize the bulls’ thesis on NVO. The company’s shares were trading ...
Novo Resources Corp is poised to begin selecting drill targets at the John Bull and Tibooburra gold projects in New South Wales, having collected hundreds of soil and rock chip samples from both ...
Mankind Pharma, India’s fourth-largest drug firm by market share, plans to come up with its generic version of Novo Nordisk’s blockbuster anti-obesity drug Semaglutide, which goes off-patent next year ...
Novo Nordisk skal have ny kommunikationsdirektør. Efter 23 år hos den danske medicinalgigant har Katrine Sperling valgt at forlade sin post. Det fremgår af et opslag på LinkedIn: 'Beslutningen ...
Han har blandt andet taget et kig på medicinalgiganten Novo Nordisk, hvis regnskab han har givet karakteren 10. Det er den højeste karakter, han har uddelt i denne regnskabssæson. Udover Novo Nordisk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback